Influvir 75 mg Capsule

About Influvir 75 mg Capsule

Influvir 75 mg 75 mg is a capsule product of Opsonin Pharma Limited that contains Oseltamivir. It is not effective against illnesses caused by agents other than influenza viruses types A and B.

There are 11 brands of Oseltamivir listed in Bangladesh. The lowest listed price is Flutavir 75 mg Capsule at ৳ 150.00 per unit.

What is Influvir 75 mg Capsule?

Made by Opsonin Pharma Limited, Influvir 75 mg is a capsule whose active ingredient is Oseltamivir. It is used to treat influenza in adults and children over one year of age when the virus is circulating in the community, and to prevent influenza in adults and adolescents who have been in contact with someone diagnosed with flu. Influvir 75 mg 75 mg is a capsule form of Oseltamivir, an antiviral medicine that belongs to the group used for respiratory viral infections such as influenza. The doctor decides the dose and course.

Uses of Influvir 75 mg

It is not effective against illnesses caused by agents other than influenza viruses types A and B. It is also used to help prevent influenza in adults and adolescents who have been in close contact with someone diagnosed with flu. Influvir 75 mg is used to treat influenza in adults and in children over one year of age when the influenza virus is circulating in the community. Your doctor will decide if it is suitable for you.

How to use Influvir 75 mg

Influvir 75 mg capsules may be taken with or without food; taking them with food may improve tolerability in some people. Influvir 75 mg is taken by mouth. Swallow the capsule whole with water. Take Influvir 75 mg 75 mg capsule exactly as the doctor tells you. If you miss a dose, ask your doctor or pharmacist what to do. Do not change the dose or stop early without asking your doctor.

Side effects of Influvir 75 mg

Less common side effects reported include unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, fever and peritonsillar abscess. The most commonly reported side effects are nausea and vomiting. Tell your doctor if you notice any side effect or if it bothers you.

Safety and precautions

It is not known whether Oseltamivir passes into breast milk, so breastfeeding mothers should use it only when the doctor decides the benefit outweighs the risk. Influvir 75 mg is not suitable for people with a known allergy to any of its ingredients. There is not enough human information to judge the risk during pregnancy, so it should be used in pregnancy only if the doctor considers it necessary. Ask your doctor before use if you are pregnant, breastfeeding, or have other health conditions.

Frequently asked questions

What does Influvir 75 mg treat?

It is not effective against illnesses caused by agents other than influenza viruses types A and B. It is also used to help prevent influenza in adults and adolescents who have been in close contact with someone diagnosed with flu.

How should I take Influvir 75 mg?

Influvir 75 mg capsules may be taken with or without food; taking them with food may improve tolerability in some people. Influvir 75 mg is taken by mouth.

What are the side effects of Influvir 75 mg?

Less common side effects reported include unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, fever and peritonsillar abscess. The most commonly reported side effects are nausea and vomiting.

Can I use Influvir 75 mg in pregnancy or while breastfeeding?

It is not known whether Oseltamivir passes into breast milk, so breastfeeding mothers should use it only when the doctor decides the benefit outweighs the risk. Influvir 75 mg is not suitable for people with a known allergy to any of its ingredients.

Indications

Oseltamivir is indicated for prevention of flu (influenza) in adults and adolescents aged 13 years and over who have been in contact with someone diagnosed with flu; treatment of flu (influenza) in adults and in children over one year of age when the influenza virus is circulating in the community

Pharmacology

Oseltamivir is a prodrug of oseltamivir carboxylate. Oseltamivir carboxylate inhibits neuraminidase (sialidase), a viral surface enzyme which is responsible for the replication and infectivity of influenza virus A and B, thereby preventing the release of viruses from infected cells.

Dosage & Administration

Oseltamivir Phosphate may be taken with or without food. However, when taken with food, tolerability may be enhanced in some patients.

Standard oral dose for the treatment of influenza:
  • Adults and Adolescents: The recommended oral dose of Oseltamivir for treatment of influenza in adults and adolescents 13 years and older is 75 mg twice daily for 5 days. Treatment should begin within 2 days of onset of symptoms of influenza.
  • Pediatric patients: The safety and efficacy of Oseltamivir for prophylaxis of influenza in pediatric patients younger than 13 years of age have not been established.
Recommended oral dose for the treatment of influenza:
  • For prophylaxis of influenza in adults and adolescents 13 years and older following close contact with an infected individual: 75 mg once daily for at least 7 days. Therapy should begin within 2 days of exposure.
  • For prophylaxis during a community outbreak of influenza: 75 mg once daily. Safety and efficacy have been demonstrated for up to 6 weeks. The duration of protection lasts for as long as dosing is continued.

Interaction

Information derived from pharmacology and pharmacokinetic studies of Oseltamivir suggests that clinically significant drug interactions are unlikely. Co-administration with amoxicillin does not alter plasma levels of either compound.

Contraindications

Oseltamivir is contraindicated in patients with known hypersensitivity to any of the components of the product.

Side Effects

The most frequently reported adverse events are nausea and vomiting. These events generally of mild to moderate degree and usually are occurred on the first 2 days of administration. Additional adverse events occurring in <1% of patients receiving Oseltamivir for treatment include unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, pyrexia, and peritonsillar abscess.

Pregnancy & Lactation

Pregnancy Category C: There are insufficient human data upon which to base an evaluation of risk of Oseltamivir Phosphate to the pregnant woman or developing fetus.

Nursing Mothers: It is not known whether oseltamivir or oseltamivir carboxylate is excreted in human milk. Oseltamivir Phosphate should, therefore, be used only if the potential benefit for the lactating mother justifies the potential risk to the breast-fed infant.

Precautions & Warnings

There is no evidence for efficacy of Oseltamivir Phosphate in any illness caused by agents other than influenza viruses Types A and B. Efficacy of Oseltamivir Phosphate in patients who begin treatment after 40 hours of symptoms has not been established.

Overdose Effects

At present there has been no experience of over dose. Single dose of up to 1000 mg of Oseltamivir have been associated with nausea and/or vomiting.

Storage Conditions

Store at 25°C. Reconstituted susp: Store between 2-8°C for up to 17 days or at 25°C for up to 10 days. Do not freeze.

Alternative brands of Oseltamivir

Other brands with the same generic name, cheapest first.

Flutavir Capsule

75 mg

Oseltamivir

Incepta Pharmaceuticals Ltd.

৳ 147 ৳ 150.00 2% off per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.